Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (201-210 of 430) with videos related to

Pageof 43
Sort By:
Kidney & Blood Pressure Research|October 11, 2014
Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patientsEiji Ishimura, Senji Okuno, Hisanori Okazaki, et al.
Nephron. Clinical Practice|November 16, 2005
Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assayTakao Tsuchida, Eiji Ishimura, Kaname Hirowatari, et al.
Case Reports in Nephrology and Dialysis|April 2, 2020
Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease PatientsShinya Nakatani, Eiji Ishimura, Yuri Machiba, et al.
Journal of Atherosclerosis and Thrombosis|October 21, 2003
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patientsShigehiko Fujiwara, Masanori Emoto, Miyoko Komatsu, et al.
Journal of Bone and Mineral Metabolism|October 19, 2004
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatmentTakami Miki, Kiyoshi Nakatsuka, Hiroshi Naka, et al.
Diabetes Care|January 31, 2006
Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjectsKatsuhito Mori, Masanori Emoto, Hisayo Yokoyama, et al.
Clinical and Experimental Nephrology|December 20, 2005
Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCAHideki Ueda, Eiji Ishimura, Takayuki Yunoki, et al.
Thrombosis Research|December 26, 2009
Association of serum TRAIL level with coronary artery diseaseKatsuhito Mori, Yuji Ikari, Shuichi Jono, et al.
Journal of Clinical & Translational Endocrinology|January 9, 2019
Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitusNorikazu Toi, Masaaki Inaba, Masafumi Kurajoh, et al.
Kidney International. Supplement|April 16, 2003
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal diseaseYoshiki Nishizawa, Tetsuo Shoji, Ryusuke Kakiya, et al.
Pageof 43

Showing results (201-210 of 430) with videos related to

Sort By:
Pageof 43
Kidney & Blood Pressure Research|October 11, 2014
Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patientsEiji Ishimura, Senji Okuno, Hisanori Okazaki, et al.
Nephron. Clinical Practice|November 16, 2005
Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assayTakao Tsuchida, Eiji Ishimura, Kaname Hirowatari, et al.
Case Reports in Nephrology and Dialysis|April 2, 2020
Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease PatientsShinya Nakatani, Eiji Ishimura, Yuri Machiba, et al.
Journal of Atherosclerosis and Thrombosis|October 21, 2003
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patientsShigehiko Fujiwara, Masanori Emoto, Miyoko Komatsu, et al.
Journal of Bone and Mineral Metabolism|October 19, 2004
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatmentTakami Miki, Kiyoshi Nakatsuka, Hiroshi Naka, et al.
Diabetes Care|January 31, 2006
Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjectsKatsuhito Mori, Masanori Emoto, Hisayo Yokoyama, et al.
Clinical and Experimental Nephrology|December 20, 2005
Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCAHideki Ueda, Eiji Ishimura, Takayuki Yunoki, et al.
Thrombosis Research|December 26, 2009
Association of serum TRAIL level with coronary artery diseaseKatsuhito Mori, Yuji Ikari, Shuichi Jono, et al.
Journal of Clinical & Translational Endocrinology|January 9, 2019
Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitusNorikazu Toi, Masaaki Inaba, Masafumi Kurajoh, et al.
Kidney International. Supplement|April 16, 2003
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal diseaseYoshiki Nishizawa, Tetsuo Shoji, Ryusuke Kakiya, et al.
Pageof 43